Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Context Therapeutics Inc. (CNTX) had Free Cash Flow per Share of $-0.25 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-26.73M |
|
-- |
|
-- |
|
$29.92M |
|
$-29.92M |
|
$3.20M |
|
$-26.73M |
|
$-26.73M |
|
$-26.73M |
|
$-26.73M |
|
$-26.73M |
|
$-26.73M |
|
$-29.92M |
|
$-29.91M |
|
58.42M |
|
58.42M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$97.90M |
|
$0.01M |
|
$0.23M |
|
$98.13M |
|
$2.75M |
|
-- |
|
$0.11M |
|
$2.86M |
|
$95.27M |
|
$95.27M |
|
$95.27M |
|
89.70M |
|
| Cash Flow Statement Financials | |
$-14.56M |
|
$-14.76M |
|
$109.29M |
|
$14.45M |
|
$94.43M |
|
$79.98M |
|
$0.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.05% |
|
-28.05% |
|
-27.24% |
|
-28.05% |
|
$1.06 |
|
|
Free Cash Flow per Share |
$-0.25 |
$-0.25 |
|